2026年6月最新影响因子数据已更新,欢迎查询使用。如果您对期刊系统有任何需求或者问题,欢迎反馈给我们。
![]() |
体验更多LetPub AI科研工具 >> | |
| 近期推荐: | 热 Wiley 2026暑期线上学习营 | 报名正式开启! | 热 最高IF18.6!生命科学SCI明星期刊集锦 | 热 肿瘤免疫/自身免疫全覆盖|免疫学SCI期刊列表 |
| |
| 基本信息 | 登录收藏 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字![]() | Translational Oncology TRANSL ONCOL (此期刊被最新的JCR期刊SCIE收录) LetPub评分 5.8
71人评分
我要评分
声誉 6.6 影响力 5.1 速度 6.2 | |||||||||||||||||||||
| 期刊ISSN | 1936-5233 | 安装APP,查看期刊最新消息
| ||||||||||||||||||||
| 2025-2026最新IF (数据来源于网友提供) | 注册或登录后,查看IF | |||||||||||||||||||||
| 实时影响因子 | 截止2026年5月06日:4.9 | |||||||||||||||||||||
| 2025-2026自引率 | 0.0%点击查看自引率趋势图 | |||||||||||||||||||||
| 五年IF (数据来源于网友提供) | 5.204数据由网友[pirate9591]收集提供 | |||||||||||||||||||||
| h-index | 41 | |||||||||||||||||||||
| CiteScore ( 2026年6月最新版) |
| |||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||
| 期刊官方网站 | https://www.journals.elsevier.com/translational-oncology | |||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||
| 期刊投稿网址 | https://www.editorialmanager.com/TRANON | |||||||||||||||||||||
| 该期刊中国学者近期发文 - New | Multi-scale evidence chain: Linking environmental BPA exposure to ovarian cancer through integrated omics and experimental models Author: Luo, Yongjin; Mo, Shipan; Song, Pengxia; Meng, Kaiyi; Zhou, Jie; Zou, Yiting Journal: TRANSLATIONAL ONCOLOGY. 2026; Vol. 69, Issue , pp. -. DOI: 10.1016/j.tranon.2026.102791 Multimodal strategies for diagnosing and treating thyroid cancer: Advances in basic and clinical research Author: Zhao, Yiyuan; Su, Yuanhao; Wu, Yongke; Mourdi, Nassuf; Ji, Yuanyuan; Wang, Zhidong Journal: TRANSLATIONAL ONCOLOGY. 2026; Vol. 69, Issue , pp. -. DOI: 10.1016/j.tranon.2026.102799 MT1G promotes the progression of ccRCC by suppressing ferroptosis through activation of the PI3K-AKT pathway Author: Zhang, Li; Sun, Jianhai; Ma, Yanling; Yan, Fei; Huang, Zhen Journal: TRANSLATIONAL ONCOLOGY. 2026; Vol. 69, Issue , pp. -. DOI: 10.1016/j.tranon.2026.102782 Overexpression of NMNAT3 suppresses melanoma progression by reprogramming NAD plus metabolism Author: Wu, Yan; Yu, Jing Journal: TRANSLATIONAL ONCOLOGY. 2026; Vol. 69, Issue , pp. -. DOI: 10.1016/j.tranon.2025.102562 | |||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Translational Oncology的语言要求,还能让Translational Oncology编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Translational Oncology编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||
| 是否OA开放访问 | Yes | |||||||||||||||||||||
OA期刊相关信息![]() | 文章处理费:需要( USD2930; ) 文章处理费豁免:查看说明 其他费用:没有 期刊主题关键词:translational oncology、cancer、genetics、endocrinology、tumour 相关链接:Aims & ScopeAuthor InstructionsEditorial BoardPeer review | |||||||||||||||||||||
| 通讯方式 | NEOPLASIA PRESS, 1150 W MEDICAL CENTER DR, MSRB III, RM 9303, ANN ARBOR, USA, MI, 48109-0648 | |||||||||||||||||||||
| 出版商 | Neoplasia Press | |||||||||||||||||||||
| 涉及的研究方向 | Biochemistry, Genetics and Molecular Biology-Cancer Research | |||||||||||||||||||||
| 出版国家或地区 | UNITED STATES | |||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||
| 出版周期 | Quarterly | |||||||||||||||||||||
| 出版年份 | 2007 | |||||||||||||||||||||
| 年文章数 | 359点击查看年文章数趋势图 | |||||||||||||||||||||
| Gold OA文章占比 | 100.00% | |||||||||||||||||||||
| 研究类文章占比: 文章 ÷(文章 + 综述) | 93.31% | |||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版:不在预警名单中 2025年03月发布的2025版:不在预警名单中 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||
| 《新锐期刊分区表》 ( 2026年3月发布) | 点击查看期刊分区表趋势图
| |||||||||||||||||||||
| 期刊分区表 ( 2025年3月升级版) |
| |||||||||||||||||||||
| 期刊分区表 ( 2023年12月旧的升级版) |
| |||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1936-5233%5BISSN%5D | |||||||||||||||||||||
| 平均审稿速度 | 网友分享经验: 较慢,6-12周 | |||||||||||||||||||||
| 平均录用比例 | 网友分享经验: 较易 | |||||||||||||||||||||
| 版面费/APC文章处理费信息 | 文章处理费:需要( USD2930; ) 文章处理费豁免:查看说明 其他费用:没有 LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦! | |||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在Translational Oncology顺利发表。
快看看作者怎么说吧:服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Multi-scale evidence chain: Linking environmental BPA exposure to ovarian cancer through integrated omics and experimental models Author: Luo, Yongjin; Mo, Shipan; Song, Pengxia; Meng, Kaiyi; Zhou, Jie; Zou, Yiting Journal: TRANSLATIONAL ONCOLOGY. 2026; Vol. 69, Issue , pp. -. DOI: 10.1016/j.tranon.2026.102791 PubMed DOI |
| 2. | Multimodal strategies for diagnosing and treating thyroid cancer: Advances in basic and clinical research Author: Zhao, Yiyuan; Su, Yuanhao; Wu, Yongke; Mourdi, Nassuf; Ji, Yuanyuan; Wang, Zhidong Journal: TRANSLATIONAL ONCOLOGY. 2026; Vol. 69, Issue , pp. -. DOI: 10.1016/j.tranon.2026.102799 PubMed DOI |
| 3. | MT1G promotes the progression of ccRCC by suppressing ferroptosis through activation of the PI3K-AKT pathway Author: Zhang, Li; Sun, Jianhai; Ma, Yanling; Yan, Fei; Huang, Zhen Journal: TRANSLATIONAL ONCOLOGY. 2026; Vol. 69, Issue , pp. -. DOI: 10.1016/j.tranon.2026.102782 PubMed DOI |
| 4. | Overexpression of NMNAT3 suppresses melanoma progression by reprogramming NAD plus metabolism Author: Wu, Yan; Yu, Jing Journal: TRANSLATIONAL ONCOLOGY. 2026; Vol. 69, Issue , pp. -. DOI: 10.1016/j.tranon.2025.102562 PubMed DOI |
| 5. | Prognostic value and therapeutic potential of the cuproptosis-related gene LOXL2 in thyroid cancer Author: Liu, Yu; Zeng, Yu; Wu, Shuping; Xu, Guangwei; Hu, Linfei; Ning, Junya; Wang, Yuqi; Tao, Mei; Luo, Wei; Hao, Jie; Zheng, Xiangqian; Gao, Ming Journal: TRANSLATIONAL ONCOLOGY. 2026; Vol. 69, Issue , pp. -. DOI: 10.1016/j.tranon.2026.102795 PubMed DOI |
| 6. | Eprenetapopt in combination with Palbociclib exerts synthetic lethality in mantle cell lymphoma Author: Dong, Ling; Zhang, Yue; Chen, Fei; Jiang, Wenxing; Qian, Siyu; Song, Wenting; Yang, Shengnan; Wu, Xiaolong; Li, Zhaoming; Zhang, Mingzhi Journal: TRANSLATIONAL ONCOLOGY. 2026; Vol. 69, Issue , pp. -. DOI: 10.1016/j.tranon.2026.102794 PubMed DOI |
| 7. | Radiotherapy and immunotherapy for advanced cancers: A meta-analysis of dose, sequencing, and survival patterns Author: Cao, Xun-Jie; He, Xing-Yu; Yang, Yang; Zhu, Qing Journal: TRANSLATIONAL ONCOLOGY. 2026; Vol. 69, Issue , pp. -. DOI: 10.1016/j.tranon.2026.102790 PubMed DOI |
| 8. | TMEM72 Inhibits the proliferation by promoting cellular senescence through the activation of the P38/MAPK signaling pathway in renal cell carcinoma Author: Dai, Fang; Wang, Huming; Chu, Wenhao; Lin, Yu; He, Jinqing; Wen, Hantao; Feng, Xiaotong; Liu, Xudong; Xu, Zihan; Bi, Liangkuan; Lyu, Zhaojie Journal: TRANSLATIONAL ONCOLOGY. 2026; Vol. 69, Issue , pp. -. DOI: 10.1016/j.tranon.2026.102789 PubMed DOI |
| 9. | Clinical validation of PEA-driven Olink proteomic discovery: INPP1 and ARHGAP25 serum biomarkers improve early breast cancer diagnosis Author: Huang, Jingchun; Gao, Lixin; Glazutdinova, Liliia; Ji, Xuyao; Zhang, Jing; Lu, Youmei; Zhang, Siyao; Liu, Yu Journal: TRANSLATIONAL ONCOLOGY. 2026; Vol. 69, Issue , pp. -. DOI: 10.1016/j.tranon.2026.102804 PubMed DOI |
| 10. | Targeting mir130b-IL-33-PD-L1 axis effectively inhibits esophageal squamous carcinoma progression Author: Yue, Ying; Xian, Wei; Yuan, Yi; Wang, Xinyue; Wu, Peng; Sha, Xiaoyu; Yue, Xiangyu Journal: TRANSLATIONAL ONCOLOGY. 2026; Vol. 69, Issue , pp. -. DOI: 10.1016/j.tranon.2026.102786 PubMed DOI |
|
|
投稿状态统计: 我要评分: | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范?试试稿件自查工具,一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验:共23条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号:沪ICP备10217908号-1
沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室